MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $264,375 | +29.7% | 4,500 | 0.0% | 0.04% | +9.1% |
| Q4 2022 | $203,895 | -35.1% | 4,500 | 0.0% | 0.03% | -38.9% |
| Q3 2022 | $314,000 | +4.0% | 4,500 | 0.0% | 0.05% | +10.2% |
| Q2 2022 | $302,000 | -18.4% | 4,500 | 0.0% | 0.05% | -2.0% |
| Q1 2022 | $370,000 | -43.9% | 4,500 | 0.0% | 0.05% | -39.8% |
| Q4 2021 | $660,000 | -17.1% | 4,500 | 0.0% | 0.08% | -23.1% |
| Q3 2021 | $796,000 | +9.5% | 4,500 | 0.0% | 0.11% | +11.3% |
| Q2 2021 | $727,000 | -5.7% | 4,500 | 0.0% | 0.10% | -11.8% |
| Q1 2021 | $771,000 | -22.0% | 4,500 | 0.0% | 0.11% | -27.6% |
| Q4 2020 | $988,000 | +32.3% | 4,500 | 0.0% | 0.15% | +13.4% |
| Q3 2020 | $747,000 | +45.3% | 4,500 | 0.0% | 0.13% | +38.1% |
| Q2 2020 | $514,000 | +48.6% | 4,500 | 0.0% | 0.10% | +22.8% |
| Q1 2020 | $346,000 | -40.3% | 4,500 | 0.0% | 0.08% | -19.4% |
| Q4 2019 | $580,000 | – | 4,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 1,992,085 | $10,877,000 | 8.55% |
| Boxer Capital, LLC | 757,935 | $4,138,000 | 3.67% |
| Avoro Capital Advisors LLC | 1,214,833 | $6,633,000 | 1.47% |
| Broadfin Capital, LLC | 693,863 | $3,788,000 | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 125,000 | $683,000 | 0.33% |
| RTW INVESTMENTS, LP | 131,052 | $716,000 | 0.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $819,000 | 0.21% |
| QVT Financial LP | 509,750 | $2,783,000 | 0.19% |
| Baker Brothers Advisors | 2,269,198 | $12,390,000 | 0.13% |
| Ghost Tree Capital, LLC | 75,000 | $410,000 | 0.12% |